242 related articles for article (PubMed ID: 9222206)
1. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas.
Gutmann DH; Giordano MJ; Fishback AS; Guha A
Neurology; 1997 Jul; 49(1):267-70. PubMed ID: 9222206
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.
Huynh DP; Mautner V; Baser ME; Stavrou D; Pulst SM
J Neuropathol Exp Neurol; 1997 Apr; 56(4):382-90. PubMed ID: 9100669
[TBL] [Abstract][Full Text] [Related]
3. The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas.
Kimura Y; Koga H; Araki N; Mugita N; Fujita N; Takeshima H; Nishi T; Yamashima T; Saido TC; Yamasaki T; Moritake K; Saya H; Nakao M
Nat Med; 1998 Aug; 4(8):915-22. PubMed ID: 9701243
[TBL] [Abstract][Full Text] [Related]
4. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
Kimura Y; Saya H; Nakao M
Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
[TBL] [Abstract][Full Text] [Related]
5. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas.
Gutmann DH; Donahoe J; Perry A; Lemke N; Gorse K; Kittiniyom K; Rempel SA; Gutierrez JA; Newsham IF
Hum Mol Genet; 2000 Jun; 9(10):1495-500. PubMed ID: 10888600
[TBL] [Abstract][Full Text] [Related]
6. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
7. Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study.
Hitotsumatsu T; Iwaki T; Kitamoto T; Mizoguchi M; Suzuki SO; Hamada Y; Fukui M; Tateishi J
Acta Neuropathol; 1997 Mar; 93(3):225-32. PubMed ID: 9083553
[TBL] [Abstract][Full Text] [Related]
8. Loss of merlin-p85 protein complex in NF2-related tumors.
Takeshima H; Nishi T; Yamamoto K; Kino T; Nakamura H; Saya H; Kochi M; Kuratsu JI; Ushio Y
Int J Oncol; 1998 May; 12(5):1073-8. PubMed ID: 9538131
[TBL] [Abstract][Full Text] [Related]
9. Universal absence of merlin, but not other ERM family members, in schwannomas.
Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization.
Begnami MD; Palau M; Rushing EJ; Santi M; Quezado M
Hum Pathol; 2007 Sep; 38(9):1345-50. PubMed ID: 17509660
[TBL] [Abstract][Full Text] [Related]
11. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
12. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas.
Mérel P; Hoang-Xuan K; Sanson M; Moreau-Aubry A; Bijlsma EK; Lazaro C; Moisan JP; Resche F; Nishisho I; Estivill X
Genes Chromosomes Cancer; 1995 Jul; 13(3):211-6. PubMed ID: 7669741
[TBL] [Abstract][Full Text] [Related]
13. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of schwannomin/merlin in human sporadic meningiomas.
Lee JH; Sundaram V; Stein DJ; Kinney SE; Stacey DW; Golubić M
Neurosurgery; 1997 Mar; 40(3):578-87. PubMed ID: 9055299
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types.
James MF; Stivison E; Beauchamp R; Han S; Li H; Wallace MR; Gusella JF; Stemmer-Rachamimov AO; Ramesh V
Mol Cancer Res; 2012 May; 10(5):649-59. PubMed ID: 22426462
[TBL] [Abstract][Full Text] [Related]
16. An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.
Stepanova DS; Semenova G; Kuo YM; Andrews AJ; Ammoun S; Hanemann CO; Chernoff J
Cancer Res; 2017 Sep; 77(18):5026-5038. PubMed ID: 28729415
[TBL] [Abstract][Full Text] [Related]
17. Human Endogenous Retrovirus Type K Promotes Proliferation and Confers Sensitivity to Antiretroviral Drugs in Merlin-Negative Schwannoma and Meningioma.
Maze EA; Agit B; Reeves S; Hilton DA; Parkinson DB; Laraba L; Ercolano E; Kurian KM; Hanemann CO; Belshaw RD; Ammoun S
Cancer Res; 2022 Jan; 82(2):235-247. PubMed ID: 34853069
[TBL] [Abstract][Full Text] [Related]
18. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669
[TBL] [Abstract][Full Text] [Related]
19. Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.
Waldt N; Scharnetzki D; Kesseler C; Kirches E; Stroscher N; Böhmer FD; Mawrin C
J Neurol Sci; 2020 Jan; 408():116553. PubMed ID: 31715329
[TBL] [Abstract][Full Text] [Related]
20. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
Sanson M
Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]